331
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Application of breast MRI for prediction of lymph node metastases – systematic approach using 17 individual descriptors and a dedicated decision tree

, , , , , & show all
Pages 885-894 | Accepted 20 Jun 2010, Published online: 25 Aug 2010

References

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
  • Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC. Early breast cancer. Lancet 2009;373:1463–79.
  • Donegan WL. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 1997;47:28–51.
  • Michaelson JS, Silverstein M, Wyatt J, Weber G, Moore R, Halpern E, . Predicting the survival of patients with breast carcinoma using tumor size. Cancer 2002;95:713–23.
  • Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181–7.
  • Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, . Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008;26:3248–58.
  • Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425–35.
  • Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, . Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008;9:10–18.
  • Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 1997;7:1002–5.
  • Loiselle CR, Eby PR, Demartini WB, Peacock S, Bittner N, Lehman CD, . Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy. Int J Radiat Oncol Biol Phys 2010;76:1314–19.
  • Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, . Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg 2007;142:855–61.
  • Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol 2008;19:822–4.
  • Komatsu S, Lee CJ, Ichikawa D, Hamashima T, Morofuji N, Shirono K, . Predictive value of the time-intensity curves on dynamic contrast-enhanced magnetic resonance imaging for lymphatic spreading in breast cancer. Surg Today 2005;35:720–4.
  • Teifke A, Behr O, Schmidt M, Victor A, Vomweg TW, Thelen M, . Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology 2006;239:351–60.
  • Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, . Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995;197:387–95.
  • Jinguji M, Kajiya Y, Kamimura K, Nakajo M, Sagara Y, Takahama T, . Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors. Breast Cancer 2006;13:64–73.
  • Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 1997;70:446–51.
  • Mussurakis S, Buckley DL, Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997;203:317–21.
  • Tuncbilek N, Karakas HM, Okten OO. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. Eur J Radiol 2005;53:199–205.
  • Chang YW, Kwon KH, Choi DL, Lee DW, Lee MH, Lee HK, . Magnetic resonance imaging of breast cancer and correlation with prognostic factors. Acta Radiol 2009;50:990–8.
  • Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, . Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 2003;39: 1068–73.
  • Dietzel M, Baltzer PA, Dietzel A, Vag T, Gröschel T, Gajda M, . Application of Artificial Neural Networks for the prediction of lymph node metastases to the ipsilateral axilla – initial experience in 194 patients using breast MRI. Acta Radiol 2010 (in press).
  • American College of Radiology (ACR). ACR BI-RADS® - MRI1. Breast imaging reporting and data system atlas (BI-RADS atlas). Fourth. Reston, VA: American College of Radiology; 2003.
  • Kaiser WA. Signs in MR-mammography. Berlin: Springer; 2007.
  • Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881–8.
  • Fischer DR, Baltzer P, Malich A, Wurdinger S, Freesmeyer MG, Marx C, . Is the “blooming sign” a promising additional tool to determine malignancy in MR mammography? Eur Radiol 2004;14:394–401.
  • Malich A, Fischer DR, Wurdinger S, Boettcher J, Marx C, Facius M, . Potential MRI interpretation model: differentiation of benign from malignant breast masses. Am J Roentgenol 2005;185:964–70.
  • Dietzel M, Baltzer PA, Vag T, Gajda M, Camara O, Kaiser WA. The hook sign for differential diagnosis of malignant from benign lesions in magnetic resonance mammography: experience in a study of 1084 histologically verified cases. Acta Radiol 2010;51:137–43.
  • Dietzel M, Baltzer PA, Vag T, Herzog A, Gajda M, Camara O, . The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases. Korean J Radiol 2010;11:178–86.
  • Edge S, Byrd D, Carducci M, Wittekind C. TNM classification of malignant tumours. New York: Springer; 2009.
  • Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403–10.
  • Cetintas SK, Kurt M, Ozkan L, Engin K, Gokgoz S, Tasdelen I. Factors influencing axillary node metastasis in breast cancer. Tumori 2006;92:416–22.
  • Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008;107:309–30.
  • Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY. Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? World J Surg 2009;33:54–7.
  • D'Eredita G, Giardina C, Martellotta M, Natale T, Ferrarese F. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 2001;37:591–6.
  • Abe H, Schmidt RA, Kulkarni K, Sennett CA, Mueller JS, Newstead GM. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy – clinical experience in 100 patients. Radiology 2009;250:41–9.
  • van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KG, Peterse JL, Rutgers EJ, . Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 2006;13:31–5.
  • Baltzer PAT, Renz DM, Herrmann KH, Dietzel M, Krumbein I, Gajda M, . Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009;19:1612–20.
  • Mountford C, Ramadan S, Stanwell P, Malycha P. Proton MRS of the breast in the clinical setting. NMR Biomed 2009;22:54–64.
  • Burke HB, Hoang A, Iglehart JD, Marks JR. Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma. Cancer 1998;82:874–7.
  • Pena-Reyes CA, Sipper M. A fuzzy-genetic approach to breast cancer diagnosis. Artif Intell Med 1999;17: 131–55.
  • Seker H, Odetayo MO, Petrovic D, Naguib RN, Bartoli C, Alasio L, . Assessment of nodal involvement and survival analysis in breast cancer patients using image cytometric data: statistical, neural network and fuzzy approaches. Anticancer Res 2002;22:433–8.
  • Vomweg TW, Teifke A, Kauczor HU, Achenbach T, Rieker O, Schreiber WG, . [Self-organizing neural networks for automatic detection and classification of contrast (media) enhancement of lesions in dynamic MR-mammography.] Rofo 2005;177:703–13 (in German).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.